(MCRB) - Earnings & Price History

MCRB: - 9.71, $407.96M, -0.33 (-3.29%)

Sector: Healthcare - Industry: Biotechnology

Seres Therapeutics, Inc., a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed open label Phase Ib/2 clinical study for the prevention of further recurrences of Clostridium difficile infection (CDI). The company also develops SER-287 that is in phase Ib clinical study to treat inflammatory bowel disease, including ulcerative colitis. Its product candidates in pre-clinical development comprise SER-262, an Ecobiotic microbiome therapeutic designed to be used following antibiotic treatment of primary CDI; and SER-155 for the prevention of transplant-related mortality. Seres Therapeutics, Inc. has a strategic collaboration with Nestle Health Science and Memorial Sloan Kettering Cancer Center

Past MCRB reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-24BMO-0.729.099.199.199.019.24-1.09%-1.09%87.44K
2017-02-23BMO-0.729.199.369.259.099.41-1.18%-0.65%-1.82%113.30K
2016-11-10BMO-0.512.9911.411.811.5613.773.51%▲10.08%13.95%971.04K
2016-08-11BMO-0.469.739.2198.929.82-2.28%8.11%5.65%1.18M
2016-08-04BMO-0.469.319.629.69.29.74-0.21%-3.02%-3.22%1.34M
2016-05-16BMO-0.4824.9523.8723.9923.55250.50%4.00%4.52%223.10K
2016-02-25-0.4124.7324.5324.5124.3425.04-0.08%0.90%0.82%145.09K
2015-11-10-0.3230.8731.4331.4630.4131.840.10%▲-1.88%-1.78%110.11K
2015-08-06-0.340.0540.0539.683840.5-0.92%0.93%78.74K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades